The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy
Objective: The objective of this study is to assess the risk of viral rebound in postpartum women on suppressive combination antiretroviral therapy (cART). Methods: Using data from the UK Collaborative HIV Cohort (UK CHIC) study and the UK and Ireland National Study of HIV in Pregnancy and Childhoo...
Main Authors: | Huntington, S. (Author), Thorne, C. (Author), Newell, M.-L (Author), Anderson, J. (Author), Taylor, G.P (Author), Pillay, D. (Author), Hill, T. (Author), Tookey, P.A (Author), Sabin, C. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2015-11.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound
by: María Rosa López-Huertas, et al.
Published: (2020-12-01) -
To rebound or not to rebound
by: Bethany A Stahl, et al.
Published: (2017-10-01) -
Mesenteric lymph nodes harbor viral reservoirs that cause viral rebound in SIV-infected macaques upon cessation of combined antiretroviral therapy
by: Horiike, Mariko
Published: (2012) -
Determinants of viral load rebound on HIV/AIDS patients receiving antiretroviral therapy: results from South Africa
by: Claris Shoko, et al.
Published: (2018-07-01) -
Using two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIV-positive women
by: Huntington Susie E, et al.
Published: (2012-07-01)